November 28, 2020
6 min watch
Save
VIDEO: Pilocarpine drives improvement in near vision in phase 2 studies
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
In this Healio Video Perspective from the virtual AAO annual meeting, Michael R. Robinson, MD, vice president, global therapeutic area head, ophthalmology, AbbVie, breaks down studies investigating presbyopia-treating eye drops.
Published by:
Sources/Disclosures
Collapse
Source:
Robinson MR. Two phase 2b study results for the development of a proprietary formulation for the treatment of presbyopia. Presented at: American Academy of Ophthalmology annual meeting; Nov. 13-15, 2020 (virtual meeting).
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.